The present invention is directed to multibinding compounds which are .beta.3 adrenergic receptor agonists and are therefore useful in the treatment and prevention of metabolic disorders such as obesity, diabetes, and the like.

A invenção atual é dirigida aos compostos multibinding que são agonists adrenergic do receptor do beta.3 e são conseqüentemente úteis no tratamento e na prevenção de disorders metabolic tais como o obesity, o diabetes, e o gosto.